Heart, Lung and Circulation
Volume 18, Issue 3 , Pages 208-213 , June 2009

Methicillin Resistant Staphylococcus aureus Endocarditis in an Australian Tertiary Hospital: 1991–2006

  • Benjamin A. Rogers, MBBS

      Affiliations

    • Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Grattan Street, Parkville 3050, Vic., Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 3 93427000; fax: +61 3 93427277.
    • ,
  • Anne K. Drake, FRACP

      Affiliations

    • Infectious Diseases Unit, The Alfred Hospital, Commercial Road, Melbourne 3004, Vic., Australia
    • ,
  • Denis Spelman, FRACP, FRCPA, MPH

      Affiliations

    • Infectious Diseases Unit, The Alfred Hospital, Commercial Road, Melbourne 3004, Vic., Australia

Received 2 June 2008 ,Revised 23 October 2008 ,Accepted 25 October 2008.

References 

  1. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162(January (1)):90–94
  2. Cheng A, Athan E, Appelbe A, McDonald M. The changing profile of bacterial endocarditis as seen at an Australian provincial centre. Heart Lung Circ. 2002;11:26–31
  3. Chang F-Y, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus Bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82(September (5)):322–332
  4. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41(August (4)):507–514
  5. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293(24):3012–3021
  6. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–638
  7. Cabell CH, Abrutyn E. Progress toward a global understanding of infective endocarditis: early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am. 2002;16(2):255–272
  8. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797
  9. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med. 1984;144(3):541–545
  10. Dwyer DE, Chen SC, Wright EJ, Crimmins D, Collignon PJ, Sorrell TC. Hospital practices influence the pattern of infective endocarditis. Med J Aust. 1994;160(11):709–713
  11. Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis. 2004;38(4):521–528
  12. Bouza E, Menasalvas A, Munoz P, Vasallo FJ, Moreno MDM, Fernandez MAG. Infective endocarditis—a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore). 2001;80(5):298–307
  13. Netzer RO, Zollinger E, Seiler C, Cerny A. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980–1995. Heart. 2000;84(1):25–30
  14. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore). 1995, Nov;74(6):324–339
  15. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317
  16. Sherwood MBS, Smith DBS, Crisel RBSE, Veledar EP, Lerakis SMD. Staphylococcus aureus endocarditis: the Grady Memorial Hospital Experience. Am J Med Sci. 2006;331(2):84–87
  17. Collignon P, Nimmo GR, Gottlieb T, Gosbell IB. Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis. 2005;11(4):554–561
  18. Hsu RB, Chu SH. Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus. Am J Med Sci. 2004, Sep;328(3):150–155
  19. Therapeutic Guidelines: antibiotic. 5th ed. North Melbourne, Victoria: Therapeutic Guidelines Limited, 1987.
  20. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, et al. Committee on Rheumatic Fever E, Kawasaki D, Council on Cardiovascular Disease in the Y, Councils on Clinical Cardiology S, Cardiovascular S, Anesthesia, American Heart A, Infectious Diseases Society of A. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e394–434
  21. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al. Task Force Members on Infective Endocarditis of the European Society of C, Guidelines ESCCfP, Document R. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J. 2004;25(3):267–276
  22. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003, Jun 1;36(11):1418–1423
  23. Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the detroit medical centre. Ann Intern Med. 1982;97:330–338
  24. Nimmo GR, Bell JM, Mitchell D, Gosbell IB, Pearman JW, Turnidge JD  on behalf of the AGAR. Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989–1999. Microb Drug Resist. 2003;9(2):155–160
  25. Nimmo G, Pearson JC, Collignon P, Christiansen KJ, Coombs GW, Bell JM, et al. Prevalence of MRSA among Staphylococcus Aureus isolated from hospital inpatients, 2005: report from The Australian Group for antimicrobial resistance. Commun Dis Intell. 2007;31(3):288–296
  26. Drees MAB, Boucher AA. New agents for Staphylococcus aureus endocarditis. Curr Opin Infect Dis. 2006;19(6):544–550

PII: S1443-9506(08)00932-3

doi: 10.1016/j.hlc.2008.10.016

Heart, Lung and Circulation
Volume 18, Issue 3 , Pages 208-213 , June 2009

Article Tools

* Image Usage & Resolution